A detailed history of Prevail Innovative Wealth Advisors, LLC transactions in Organon & Co. stock. As of the latest transaction made, Prevail Innovative Wealth Advisors, LLC holds 72,656 shares of OGN stock, worth $1.5 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
72,656
Previous 231,375 68.6%
Holding current value
$1.5 Million
Previous $3.34 Billion 59.06%
% of portfolio
0.51%
Previous 1.59%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$13.78 - $18.8 $2.19 Million - $2.98 Million
-158,719 Reduced 68.6%
72,656 $1.37 Billion
Q4 2023

Feb 13, 2024

BUY
$10.95 - $17.32 $2.53 Million - $4.01 Million
231,375 New
231,375 $3.34 Billion

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $5.26B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Prevail Innovative Wealth Advisors, LLC Portfolio

Follow Prevail Innovative Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prevail Innovative Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prevail Innovative Wealth Advisors, LLC with notifications on news.